Development of Hepatic Steatosis After Chemotherapy for Non-Hodgkin Lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of Hepatic Steatosis After Chemotherapy for Non-Hodgkin Lymphoma

Published:2018-12-28 Issue:2 Volume:3 Page:220-226
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Ben-Yakov Gil¹^ORCID,Alao Hawwa¹²,Haydek John P.¹,Fryzek Nancy¹,Cho Min Ho¹³,Hemmati Mehdi¹⁴,Samala Vikram¹,Shovlin Margaret⁵,Dunleavy Kieron⁵,Wilson Wyndham⁵,Jones Elizabeth C.⁶,Rotman Yaron¹^ORCID

Affiliation:

1. Liver and Energy Metabolism Unit, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Bethesda MD

2. Department of Gastroenterology; Louis Stokes VA Medical Center; Cleveland OH

3. Department of Medicine; MedStar Washington Hospital Center; Washington DC

4. Department of Medicine; MedStar Health; Baltimore MD

5. Lymphoid Malignancies Branch, Center for Cancer Research; National Cancer Institute, National Institutes of Health; Bethesda MD

6. Radiology and Imaging Sciences; National Institutes of Health Clinical Center; Bethesda MD

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

Publisher

Wiley

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep4.1304/fullpdf

Reference24 articles.

1. How healthy are the “Healthy volunteers”? Penetrance of NAFLD in the biomedical research volunteer pool;Takyar;Hepatology,2017

2. Nonalcoholic fatty liver disease and liver transplantation-where do we stand?;Mikolasevic;World J Gastroenterol,2018

3. The role of nonalcoholic fatty liver disease on cardiovascular manifestations and outcomes;Kovalic;Clin Liver Dis,2018

4. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population;Stepanova;Clin Gastroenterol Hepatol,2012

5. Long-term follow-up of patients with NAFLD and elevated liver enzymes;Ekstedt;Hepatology,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic safety profile of pancreatic cancer‑bearing mice fed a ketogenic diet in combination with gemcitabine;Oncology Letters;2023-09-22

2. The chemotherapeutic drug doxorubicin does not exacerbate p16Ink4a-positive senescent cell accumulation and cardiometabolic disease development in young adult female LDLR-deficient mice;Toxicology and Applied Pharmacology;2023-06

3. Concomitant Sub-Chronic Administration of Small-Size Gold Nanoparticles Aggravates Doxorubicin-Induced Liver Oxidative and Inflammatory Damage, Hyperlipidemia, and Hepatic Steatosis;Molecules;2023-01-13

4. Clearing Steatosis Prior to Liver Surgery for Colorectal Metastasis: A Narrative Review and Case Illustration;Nutrients;2022-12-15

5. Identification of biomarkers in nonalcoholic fatty liver disease: A machine learning method and experimental study;Frontiers in Genetics;2022-11-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3